Failure of Direct-Acting Antiviral Agents Due to Incomplete Hepatitis C Virus Genotyping
Journal Title: Viral Hepatitis Journal - Year 2018, Vol 24, Issue 3
Abstract
Current direct-acting antivirals (DAAs) have high success rates in the treatment of chronic hepatitis C virus (HCV) infection. However, 1-15% of patients fail to achieve viral eradication. Some factors may play a role in the treatment failure and relapse. In this paper, we present two cases of hepatitis C in which DAAs failed due to incomplete HCV genotyping.
Authors and Affiliations
Esragül AKINCI, Esra YURDCU, Bahadır ORKUN ÖZBAY, Hürrem BODUR
Keywords
Related Articles
- EP ID EP427190
- DOI 10.4274/vhd.2018.0022
- Views 73
- Downloads 0
Epidemiology of Viral Hepatitis Changes in Our Country
.
Distribution of Hepatitis C Virus Genotypes in the Region of İstanbul Northern Anatolian Association of Public Hospitals
Objective: Hepatitis C virus (HCV) is responsible for 20% of acute hepatitis and 70% of chronic hepatitis. Determination of HCV genotype is important in the regulation of treatment and the follow-up of clinical course. I...
Evaluation of Chronic Hepatitis C Patients from Different Aspects Before the Use of Direct Acting Antivirals
Objective: Chronic hepatitis C (CHC) virus infection is one of the leading causes of chronic liver disease in all over the world. The prevalence of CHC is almost 0.5-1% in Turkey. Until recently, pegylated-interferon (PE...
2018 Referee Index
Empty
Current Treatment Approach in Acute Hepatitis C Infection
Acute hepatitis C virus (HCV) infection has an asymptomatic course in most patients. There is no sufficient data regarding its epidemiological features. Recent advances in the treatment of chronic HCV infection have led...